Practical Immuno-PET Radiotracer Design Considerations for Human Immune Checkpoint Imaging
Biodistribution
Immune checkpoint
DOI:
10.2967/jnumed.116.177659
Publication Date:
2016-12-16T02:52:51Z
AUTHORS (8)
ABSTRACT
Immune checkpoint blockade has emerged as a promising cancer treatment paradigm. Unfortunately, there are still large number of patients and malignancies that do not respond to therapy. A major barrier validating biomarkers for the prediction monitoring responders clinical been lack imaging tools accurately assess dynamic immune expression. Here, we sought optimize noninvasive immuno-PET human programmed death-ligand 1 (PD-L1) expression, in preclinical model, using small high-affinity engineered protein scaffold (HAC-PD1). Six HAC-PD1 radiotracer variants were developed used biodistribution studies their ability detect PD-L1 expression vivo. Radiotracer design modifications included chelate, glycosylation, radiometal. HACA-PD1 was adopted naming convention aglycosylated tracer variants. NOD scid γ-(NSG) mice inoculated with subcutaneous tumors either be constitutively positive (CT26 hPD-L1) or negative (ΔmPD-L1 CT26) When had grown an average size cm diameter, injected 0.75-2.25 MBq (∼10 μg) variant imaged. At h after injection, organs harvested biodistribution. Of practical considered, glycosylation most prominent factor affecting uptake, specificity, clearance. In studies, 64Cu-NOTA-HACA-PD1 visualized We reasoned because scaffold's (14 kDa), its pharmacokinetics may suitable labeling short-lived widely clinically available radiometal 68Ga. 68Ga-NOTA-HACA-PD1 68Ga-DOTA-HACA-PD1 exhibited target-to-background ratios ex vivo (12.3 15.2 tumor-to-muscle ratios, respectively). Notably, all enabled much earlier detection (1 injection) than previously reported radiolabeled antibodies (>24 injection). This work provides template assessing parameters supports translation radiotracers checkpoints.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (33)
CITATIONS (99)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....